All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Current Regulatory Landscape in Antibiotic Stewardship

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.
A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) 

 View more SIDPEC Activities

Activity Description

The regulatory landscape of antimicrobial stewardship has changed greatly since 2012 as part of coordinated national and international efforts to combat antimicrobial resistance. This offering will provide an update of the current regulatory requirements regarding stewardship and describe initiatives and proposed rules on the horizon from government agencies and other organizations. This will include a discussion of stewardship in the acute care, ambulatory and long-term care settings. Other areas of opportunity for stewardship programs including formats for benchmarking antibiotic use through the National Healthcare Safety Network (NHSN) Antimicrobial use and resistance (AUR) module and available incentives to report will also be reviewed.

This is a featured CE activity on the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) website. SIDPEC is the educational hub of the Society of Infectious Diseases Pharmacists (SIDP). The SIDPEC portal provides educational activities on infectious disease pharmacotherapy for clinical pharmacists, health‐systems pharmacists, community pharmacists, and other allied‐health disciplines.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Outline current regulatory requirements governing stewardship in the US
  • Describe possible regulatory initiatives on the horizon
  • List state regulatory initiatives surrounding antimicrobial stewardship


Elizabeth Dodds-Ashley, PharmD, MHS, FCCP, BCPS
Associate Professor of Medicine
Co-Director of Operations, Duke Antimicrobial Stewardship Outreach Network
Department of Medicine, Division of Infectious Diseases and International Health
Duke University
Durham, North Carolina


No commercial funding was received for this activity.

CE Accreditation

Release Date: 7-21-2017
Expiration Date: 7-21-2020


APCE This CE activity is jointly provided by ProCE, Inc. and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-136-H04-P has been assigned to this knowledge-based home-study CE activity (initial release date 7-21-2017). This CE activity is approved for 0.75 contact hour (0.075 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.


It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. Dr. Dodds-Ashley has served as a Speaker and/or Consultant for the Greater New York Hospital Association (GNYHA), the Healthcare Association of New York State (HANYS), the New York State Council of Health-system Pharmacists (NYSCHP), and the Society for Healthcare Epidemiology of America (SHEA).

Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Download Handout